Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis

Authors
Category Primary study
ConferenceBritish Journal of Haematology
Year 2021
This article has no abstract
Epistemonikos ID: 7661a9070da45d64afa6b3d3e1576fa27d739bf0
First added on: Apr 30, 2026